Advertisement
 
Skip navigation links
About Us
Members
Fellows in Training
Allied Health Professionals
Alliance
Patients & Public
ACAAI Foundation
Newsroom
Sponsors
Annual Meeting
Skip navigation links
About Us
Members
Fellows in Training
Allied Health Professionals
Alliance
Patients & Public
ACAAI Foundation
Newsroom
Annual Meeting
ACAAI - Faces Facets Allergy Immunology 2014
Benefits
Al Jarreau
Named Lectures
Practice management, literature review and more for allied health professionals
Board Review

Explore New Frontiers in Allergy and Immunology


ACAAI President-Elect Michael Foggs, MD, FACAAI

Join your colleagues at the 70th ACAAI Annual Scientific Meeting in Baltimore, Md., Nov. 7-11, titled New Frontiers in Allergy and Immunology: From Bench to Clinic.

“Allergists are facing challenging times,” said Michael Foggs, MD, FACAAI, president-elect and program chair. “Despite the fact that we offer unique services and value to our patients and to society, there have been encroachments on the territorial domain of our discipline. The health care paradigm has been shifting towards primary care with diminishing recognition of the value and importance of cognitive specialties and subspecialties.

“These new realities make it necessary for allergists to position themselves to be able to endure and overcome these growing pressures that potentially threaten our survival as a sustainable discipline. One way we intend to accomplish this goal is to provide valuable information at the Annual Meeting in a variety of areas. Scientific programs will expand knowledge and open new doors for clinical application opportunity, in areas ranging from the traditional allergic diseases that allergists have been managing for decades, to clinical application of disease states that will represent new areas for some,” he said.

Our opening program on Thursday, Nov. 7, “Emerging Forms of Immunotherapy,” will focus on the science behind sublingual immunotherapy (SLIT) and where and when to consider it. It will review what constitutes clinically meaningful effect, recent findings in pediatric clinical trials with SLIT, perennial versus discontinuous treatment with SLIT, assessment of randomized clinical trials comparing subcutaneous immunotherapy (SCIT) versus SLIT, and review accelerated immunotherapy schedules and emerging novel forms of immunotherapy.

“Beginning on Friday, Nov. 8, a number of clinical symposia will address perplexing challenges in allergy and immunology, and revisit some of the common clinical options for therapeutic interventions for a variety of disorders,” Dr. Foggs said.

Saturday, Nov. 9, includes three exciting Plenary Sessions:

  • “Expanding the Role of the Allergist” will discuss salient facets of genomics, microbiomics, and nanomedicine.
  • “COPD and Asthma: Exploring Immmunopathophysiological Mechanisms” will include the immunology of COPD, identifying the mechanisms of severe asthma, and take a new look at both COPD and asthma by revisiting the Dutch hypothesis.
  • This year's Great Raft Debate — “The Eyes Have It! Which Eye Disorder Poses the Greatest Therapeutic Challenge?”— will be a lively debate of some of the most challenging ocular disorders and their treatments. The winner takes all!

On Sunday, Nov. 10, don't miss two very important Plenary Sessions:

  • “Exciting Issues in Food Allergy” will address whether food allergy can be prevented.
  • “Navigating the Rapids of the Regulatory Alphabet Soup: Survival Tips for the Practicing Allergist” will cover some pressing practice issues that allergists face.

Finally, on Monday, Nov. 11, three plenary sessions and the Bela Schick Lecture will mark the conclusion of our Annual Meeting. These programs include:

  • “Special Issues in Women with Atopy and Autoimmune Diseases” will focus not only on gender differences in allergic and immunologic disease states, but also on what can be done to prevent allergy during pregnancy and breast feeding.
  • “Immunology Updates in Other Specialties: What Allergists Need to Know Now” will highlight some of the cutting-edge clinical pearls from other disciplines that will be useful to us in our clinical practices in assessing and treating our patients.
  • In “Current Trends in Rhinitis Assessment and Therapy,” our speakers will provide exceptional breadth and depth to new advances in allergen immunotherapy and discuss chronic rhinitis subtypes and relationship between headaches and rhinitis.

The meeting also entails the Friday Literature Review, a variety of workshops, Meet the Professor Breakfasts, and informative symposia – all addressing cutting edge issues in allergy and immunology.

Enable your allied health professionals to attend the special courses specifically tailored to their needs which are aimed at improving the quality of patient care.

Our host city of Baltimore provides plenty of opportunities to explore new frontiers outside the convention center. Located on the Chesapeake Bay, it’s easy to get around and enjoy the many activities the city has to offer.

“The ACAAI Annual Scientific Meeting will be an exciting and memorable learning experience that will allow us to conquer new frontiers in allergy and immunology and at the same time maintain and nourish the cherished camaraderie that makes the College thrive,” Dr. Foggs said.

 
Copyright 2012 - American College of Allergy, Asthma & Immunology | 85 West Algonquin Road, Suite 550 | Arlington Heights, IL 60005











website designed and maintained by Washington Graphic Services